26 funds hold it.2 straight earnings beats.
No insider open-market trades in 90 days (SEC Form 4). Congress: net buying of $2K to $30K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Oct 23, 2026
Period ending
Sep 30, 2026
Earnings per share
$1.54 expected
Estimates as of Oct 25, 2026
EPS expected
$1.46 to $1.47
Revenue expected
3 analysts
Last 30 days
Analysts raising estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 23, 2026 | $1.57 / $1.54Yahoo Finance | +1.73% beat | $290.7M No estimateSEC filing | Unavailable |
| Jun 30, 2026 | Jul 31, 2026 | $1.49 / $1.43Yahoo Finance | +4.56% beat | $284.0M No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $1.33 / $1.33Yahoo Finance | +0.00% in line | $270.7M No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 20, 2026 | $1.31 / $1.28Yahoo Finance | +1.95% beat | $263.6M No estimateSEC filing | Unavailable |
| Sep 30, 2025 | Oct 21, 2025 | $1.35 / $1.31Alpha Vantage | +3.05% beat | $267.6M No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $1.27 / $1.25Alpha Vantage | +1.60% beat | $255.5M No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | $1.22 / $1.22Alpha Vantage | +0.00% in line | $250.5M No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Feb 21, 2025 | $1.13 / $1.10Alpha Vantage | +2.26% beat | $240.0M No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $263.6M | $270.7M | $284.0M | $290.7M |
| Cost of what it sold | $169.7M | $169.6M | $180.3M | $184.9M |
| Gross profit | $93.9M | $101.1M | $103.7M | $105.7M |
| What it spent | ||||
| Research and development | $5.1M | $5.9M | $4.5M | $5.3M |
| Sales and admin | $1.1M | $18.5M | $18.8M | $17.2M |
| Other operating costs | $27.6M | $21.1M | $21.2M | $20.7M |
| Total operating expenses | $33.8M | $45.5M | $44.5M | $43.3M |
| What was left | ||||
| Operating profit | $60.1M | $55.6M | $59.2M | $62.4M |
| Interest on debt | $2.2M | $3.1M | $1.4M | $1.9M |
| Profit before tax | $50.0M | $52.5M | $57.8M | $60.0M |
| Tax | $10.8M | $12.2M | $13.2M | $13.3M |
| Net profit | $39.2M | $40.3M | $44.6M | $46.7M |
| EBITDA | $63.9M | $67.2M | $71.4M | $72.4M |
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Balchem Releases Q3 2026 Financial Results
BullishOct 23Balchem Corp Estimates – BMV:BCPC
NeutralOct 23Balchem third quarter sales rise 8.6% to $290.7 million
BullishOct 23Press Release: Balchem Corporation Reports Third Quarter 2026 Financial Results
BullishOct 23Quarterly sales and profit set records at Balchem. Sales reached $290.7 million.
BullishOct 23Balchem Corporation (BCPC) Stock Forecasts
NeutralOct 15Pretax income of Balchem Corp – HAN:BL9B
NeutralOct 15Non-operating income (total) of Balchem Corp – HAN:BL9B
NeutralOct 12